# Thiol Disulfide Balance in Cervix Cancer

> **NCT04258553** · — · COMPLETED · sponsor: **Muğla Sıtkı Koçman University** · enrollment: 123 (actual)

## Conditions studied

- Cervix Cancer
- Oxidative Stress

## Interventions

- **DIAGNOSTIC_TEST:** Disulphide(μmol/L)
- **DIAGNOSTIC_TEST:** Total Oxidant Capacity(μmolH2O2Equiv/L)
- **DIAGNOSTIC_TEST:** Ischemia Modified Albumin(IU/mL)

## Key facts

- **NCT ID:** NCT04258553
- **Lead sponsor:** Muğla Sıtkı Koçman University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2020-01-20
- **Final completion:** 2020-02-04
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2020-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04258553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04258553, "Thiol Disulfide Balance in Cervix Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04258553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*